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Abstract 1 
Background and objective: Patient medicines helpline services (PMHS) are available from some 2 
National Health Service Trusts in the United Kingdom to support patients following discharge. The 3 
aim of this systematic review was to examine the available evidence regarding the characteristics of 4 
enquirers and enquiries to PMHS, in order to develop recommendations for service improvement. 5 
Methods: Searches were conducted using Medline, EMBASE, CINAHL, Scopus, and Web of Science, 6 
on 4th June 2019. Forward and backward citation searches were conducted, and grey literature was 7 
searched. Studies were included if they reported any characteristics of enquirers who use PMHS, 8 
and/or enquiries received. Study quality was assessed using the AXIS tool. A narrative synthesis was 9 
conducted, and where appropriate, weighted means (WM) were calculated. Where possible, 10 
outcomes were compared to Hospital Episode Statistics (HES) data for England, to establish whether 11 
the profile of helpline users may differ to that of hospital patients.  12 
Results: Nineteen studies were included (~ 4423 enquiries). Risk of bias from assessed studies was 13 
71%. Enquirers were predominantly female (WM = 53%; HES mean = 57%), elderly (WM = 69 years; 14 
HES mean = 53 years), and enquired regarding themselves (WM = 72%). Out of inpatient and 15 
outpatient enquirers, 50% were inpatients and 50% were outpatients (WM). Six of fourteen studies 16 
reported adverse effects as the main enquiry reason. Two of four studies reported antimicrobial 17 
drugs as the main enquiry drug class. From two studies, the main clinical origin of enquiries were 18 
general surgery and cardiology. Across six studies, 27% (WM) of enquiries concerned medicines-19 
related errors. 20 
Conclusions: Our findings show that PMHS are often used by elderly patients, which is important 21 
since this group may be particularly vulnerable to experiencing medicines-related issues following 22 
hospital discharge. Over a quarter of enquiries to PMHS may concern medicines-related errors, 23 
suggesting that addressing such errors is an important function of this service. However, our study 24 
Running Head: Hospital-based patient medicines helpline services 
 
Page 3 of 28 
 
findings may be limited by a high risk of bias within included studies. Further research could provide 1 
a more detailed profile of helpline users (e.g., ethnicity, average number of medicines consumed), 2 
and we encourage helpline providers to use their enquiry data to conduct local projects to improve 3 
hospital services (e.g., reducing errors). 4 
Registration: PROSPERO CRD42018116276.  5 
 6 
Keywords: systematic review, patient medicines helplines, National Health Service, medicines 7 
information, drug information, hospital pharmacy. 8 
 9 
  10 
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BACKGROUND 1 
Approximately 40% of patients who have been discharged from hospital may experience 2 
medicines-related problems [1, 2]. Additionally, patients often lack knowledge about their 3 
medications following hospital discharge [3, 4], and many patients report not receiving important 4 
medicines-related information [5, 6]. Patients may also experience medicines-related errors 5 
following hospital discharge, such as dispensing errors and incorrect or missing information on 6 
discharge documents [7, 8]. Hospital discharge may therefore be a confusing and/or risky period for 7 
patients who have recently experienced changes to their medicines.  8 
Consequently, in the UK, hospital-based patient medicines helpline services (PMHS) have 9 
become available from some NHS Trusts.  The first PMHS was established in the UK in 1992 [9], and 10 
a survey study conducted in 2017 found that 52% of NHS Trusts provided a PMHS [10]. The function 11 
of a PMHS is to enable discharged patients to seek medicines-related support from pharmacy 12 
professionals from the healthcare setting where they recently received care. This accords with World 13 
Health Organisation (WHO) policy, which states that offering information on medicines via 14 
Medicines Information (MI) centres, and providing public education about medicines, are two of 15 
twelve essential interventions to promote the rational use of medicines [11]. 16 
Studies that have examined PMHS have typically been service evaluations of individual sites to 17 
describe the characteristics of enquirers and their enquiries, and to report the effectiveness of PMHS 18 
using enquirer satisfaction surveys (e.g., [12, 13]). A recent systematic review examined the 19 
evidence regarding the effectiveness of PMHS, concluding that they are typically perceived as 20 
positive, advice is usually followed, and users report several positive outcomes (e.g., problems 21 
resolved/avoided, and improved health) [14]. However, to date, a review of the literature has not 22 
been conducted which brings together the available evidence regarding the characteristics of 23 
enquirers to PMHS, nor the enquiries they make. The findings of such a review would be more 24 
generalisable to PMHS throughout the UK than individual service evaluations. Such information 25 
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could be useful for establishing whether PMHS are under-used by any types of patients, and for 1 
understanding patients’ needs, which could highlight areas for service improvement.  2 
Aim 3 
The aim of this systematic review was to address the following research questions, in order 4 
to develop recommendations for improving PMHS, and potentially, hospital pharmacy services more 5 
widely: What are the characteristics of people who use PMHS? What are the characteristics of 6 
enquiries made to PMHS? 7 
METHODS 8 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses were used in the 9 
planning, conducting, and reporting of this review. The protocol was registered with the 10 
International Prospective Register of Systematic Reviews on 21st November 2018 (registration 11 
number CRD42018116276) [15].  12 
Eligibility criteria 13 
Studies were included if they reported any characteristics of enquirers who use PMHS, 14 
and/or enquiries received. PMHS were defined as: (1) a service for patients and/or carers of patients 15 
who received care from the NHS Trust within the UK that provides the PMHS, and not for a specific 16 
subset of patients and/or their carers; (2) a service involving distance communication, via any 17 
means, between the service user and service provider, instigated by the service user; and (3) a 18 
service providing MI, and not general clinical information.  19 
We included published and unpublished studies, abstracts, and conference proceedings that 20 
were written in English. We excluded studies if the data were presented in a subsequently published 21 
format (e.g., a study in a conference proceeding if it was subsequently published as a full-text 22 
article). No restriction was made regarding year of publication. 23 
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Studies were only included where the types of enquirers and/or enquiries were based upon 1 
either the total number of all enquiries received within a specified period (e.g., six months), or a 2 
randomly selected number of enquiries from all enquiries received within a specified period. Studies 3 
were excluded if they solely described a subset of all enquirers or enquiries (e.g., only female 4 
enquirers, or enquiries about adverse effects), since the focus was upon PMHS, and not upon 5 
specific patient groups, issues, or conditions. 6 
Search strategy 7 
Searches were conducted using Medline, EMBASE, CINAHL, Scopus, and Web of Science. 8 
Where possible, searches were conducted using both free-text and subject headings. The search 9 
strategy was determined for EMBASE, and subsequently adapted to the syntax and subject headings 10 
of the other databases (see Supplementary Information 1 for the EMBASE search strategy). Searches 11 
were conducted on 1st August 2017 and updated on 4th June 2019. Forward and backward citation 12 
searches were conducted for all included studies. Forward citation searches were conducted on 4th 13 
June 2019, using Scopus, Web of Science, and Google Scholar. 14 
The following grey literature sources were searched: grey literature databases, Google and 15 
Google Scholar, conferences proceedings, and consultation with experts (see Supplementary 16 
Information 2 for further details).  17 
Screening and selection of studies 18 
Database search results were exported to Covidence [16], duplicates were removed, and 19 
studies were screened and selected. Two researchers independently screened all titles and abstracts 20 
for relevance, and disagreements were resolved by discussion. Articles meeting the inclusion criteria, 21 
or where there was uncertainty, were obtained in complete form. Full text reports were 22 
independently examined against the inclusion criteria by two researchers, and disagreements were 23 
resolved by discussion.  24 
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Data extraction 1 
Data extraction was conducted by one researcher using a data extraction form, with 20% 2 
verified by another researcher (see Supplementary Information 3 for the data extraction form). No 3 
discrepancies were found. Details from all data extraction forms were entered in to an excel 4 
spreadsheet, in preparation for analysis.  5 
Raw data were not analysed for this systematic review.  However, where there was the 6 
potential to attain data in a more relevant format, authors of studies were contacted (e.g., to ask if 7 
they would be willing to provide the mean age of enquirers from their retrospective review of 8 
enquiries). 9 
Quality assessment of included studies 10 
The AXIS tool [17] was chosen to assess risk of bias and quality within studies. This tool 11 
comprises 20 items for assessing cross-sectional studies, and is composed of three subscales. The 12 
subscales measure risk of bias (i.e., selection bias, measurement bias, non-response bias, and 13 
reporting bias; e.g., ‘Was the selection process likely to select subjects/participants that were 14 
representative of the target/reference population under investigation?’), quality of reporting (e.g., 15 
‘Were the methods (including statistical methods) sufficiently described to enable them to be 16 
repeated?’), and quality of study design (e.g., ‘Was the study design appropriate for the stated 17 
aim(s)?’). The assessment of risk of bias and quality were used for information, and not to exclude 18 
studies. Each included study, for which there was a full report, was independently appraised by two 19 
researchers. Only full reports were appraised, since they contained enough information to 20 
adequately assess risk of bias and quality of reporting compared to, for example, conference 21 
abstracts. Disagreements were resolved through discussion.  22 
Narrative synthesis 23 
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Findings were synthesised in a narrative synthesis around the study objectives, following the 1 
guidelines by Popay et al. [18]. Where possible, weighted averages were calculated across studies to 2 
account for varying sample sizes. Additionally, where possible, outcomes were compared to Hospital 3 
Episode Statistics (HES) admitted patient care and outpatient data for England, to examine the 4 
representativeness of PMHS enquirers. Since the years of data collection varied across studies, the 5 
average of HES data for the past five years were used (2013-14 to 2017-18; [19]).  6 
RESULTS 7 
Study selection 8 
Nineteen studies were identified for inclusion in this review. Figure 1 shows a flow diagram 9 
of the study selection process. 10 
Study characteristics 11 
Included studies are presented in Table 1. Eight studies contained data regarding the 12 
characteristics of enquirers of PMHS. Eighteen studies contained data regarding the types of 13 
enquiries made to PMHS. All studies were retrospective reviews of enquirers and/or enquiries.  14 
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Table 1. Studies meeting eligibility criteria for the systematic review of the characteristics of enquirers and enquiries to patient 
medicines helpline services. 
First author, Year 
published 
Study 
source 
Study 
design 
Country of study 
Data collection year/s 
(weeks/months) a 
Number of 
enquiries 
  Outcomes 
  Enquirers Enquiries 
Adam, 2004 [20] CA RRE England 2003 (1 week) 90 
 
X X 
Badiani, 2017 [13] PS-PR RRE England 2015 (9 months) 637 
  
X 
Bramley, 2014 [12] PS-PR RRE United Kingdom 2009 (12 months) 312 
 
X X 
Bruce, 1995 [21] PS-BR RRE Scotland 1994-1995 (12 months) 111 
  
X 
Burgess, 2009 [22] CA RRE England 2008 (1 month) 17 
 
X 
 
Cooke, 2010 [23] CA RRE England 2009-2010 (NR) 56 
  
X 
Cuthbert, 2013 [24] CA RRE Scotland NR (6 weeks) 18 
 
X X 
Dhillon, 2001 [25] PS-PR RRE England NR (3 months) 109 
 
X X 
Dugdale, 2018 [26] CA RRE England 2016-2017 (24 months) 538   X 
Hynes, 2013 [27] CA RRE England 2011-2012 (12 months) 209 
  
X 
Jones, 2014 [28] CA RRE England 2012-2014 (NR) 234 
  
X 
Law, 2015 [29] CA RRE England 2015 (4 months) 109 
  
X 
Martin, 2014 [30] LE RRE Wales 2012-2013 (12 months) 262 
 
X X 
Marvin, 2011 [31] PS-PR RRE England 2008 (6 months) 500 
  
X 
Price, 2011 [32] CA RRE England 2010-2011 (NR) 51 
  
X 
Raynor, 1994 [9] PS-BR RRE England NR (NR) NR 
  
X 
Sims, 1996 [33] CA RRE England NR (NR) > 1000 b 
  
X 
Teli, 2001 [34] CA RRE England 1999 (NR) NR 
 
X X 
Williams, 1994 [35] PS-PR RRE England 1993 (NR) 170 
 
X X 
Note. Abbreviations: CA = conference abstract; LE = letter to the editor; NR = not reported; PS-BR = study published as a brief report; 
PS-PR = published study in a peer reviewed journal; RRE = retrospective review of enquiries. 
a Of the included studies, the data collection period ranged from one week to twelve months (mean = approximately 31 weeks; seven 
studies did not report the data collection period length).   
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b This study reported their sample size as 'over 1000'. 
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Quality assessment and risk of bias within studies 1 
Five studies met our criteria for quality and risk of bias assessment. The overall score and 2 
percentage of quality and risk of bias for these studies are presented in Table 2. Fleiss Kappa was 3 
conducted, showing that there was substantial agreement between raters [36], K = .72 (95% CI, .56 4 
to .88), p = .000. 5 
 6 
Table 2. Quality assessment and risk of bias in full reports of studies meeting eligibility criteria for the 
systematic review. 
First author, Year published Total a RoB b QoR QoSD 
Badiani, 2017 [13] 50% (10/20) 50% (3/6) 57% (4/7) 43% (3/7) 
Bramley, 2014 [12] 63% (12/19) 40% (2/5) 71% (5/7) 57% (4/7) 
Dhillon, 2001 [25] 29% (5/17) 100% (3/3) 14% (1/7) 57% (4/7) 
Marvin, 2011 [31] 65% (11/17) 67% (2/3) 71% (5/7) 71% (5/7) 
Williams, 1994 [35] 35% (6/17) 100% (3/3) 43% (3/7) 43% (3/7)      
Average (mean) percentage 48% 71% 51% 54% 
Note. Abbreviations: QoR = quality of reporting score (out of a maximum score of 7); QoSD = quality of 
study design score (out of a maximum score of 7); RoB = risk of bias score (out of a maximum score of 
6). 
a Quality assessment was measured using the AXIS tool, developed by Downes et al. (2016). Depending 
on the study design, not all RoB items were relevant (i.e., three RoB items pertain to non-response 
bias, and three of the studies did not recruit study participants since their aim was to only assess PMHS 
enquiries. Additionally, the study by Bramley (2014) recruited study participants with no non-
responders, thus rendering one item obsolete). This accounts for the different maximum Total scores 
and RoB scores across studies. 
  
b The Risk of Bias items were reversed, so that the reported percentages reflect the amount of 
potential bias in each study. However, the AXIS total score was calculated without reversing the Risk of 
Bias items, to ensure that the reported total score percentages reflect the amount of positively coded 
items in the tool. This accounts for the discrepancy between the total score and the sum of the 
subscales for each study.  
 7 
 8 
Characteristics of enquirers 9 
Table 3 presents eight studies that reported data regarding the characteristics of enquirers. 10 
Enquirers are predominantly female, elderly, and enquiring for themselves. 11 
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Table 3. Characteristics of enquirers who use patient medicines helpline services 
First author, Year published N Mean age % female % enquired for self 
% repeat 
callers 
% discharged 
inpatients 
% outpatients 
Adam, 2004 [20] 90 ― 62% ― ― ― ― 
Bramley, 2014 [12] 312 ― 50% 70% ― ― ― 
Burgess, 2009 [22] 17 ― ― 76% ― 40% c 60% c 
Cuthbert, 2013 [24] 18 70 (SD = 15) 61% 56% ― ― ― 
Dhillon, 2011 [25] 109 ― 63% 64% 15% ― ― 
Martin, 2014 [30] 262 69 (SD = NK) 50% 79% ― 51% d 49% d 
Teli, 2001 [34] NR ― ― ― ― 72% 18% 
Williams, 1994 [35] 170 ― ― ― 4% ― ― 
        
Average (mean) 
 
70 57% 69% 10% 54% 42% 
Weighted average (mean) 
 
69 53% 72% 8% 50% e 50% e 
HES data, where available 
 
53 a 57% b ― ― 18% 82% 
Note. Abbreviations: HES = Hospital episode Statistics; NK = not known; NR = not reported. Part of the data for the studies by Cuthbert et al. and Martin et 
al. was obtained from the authors via personal communication.  
a Range of mean ages over five years of HES data = 52 years to 54 years. Only HES admitted patient care data were used, since mean age was not reported 
in HES outpatient datasets. 
b Range of percentages over five years of HES data = 57% to 58% 
c In the study by Burgess, 2009, two service users were members of the public. Therefore, in order to only use the data regarding inpatients and 
outpatients, we calculated the percentages of discharged inpatients and outpatients using only the total number of callers who were discharged inpatients 
or outpatients (n = 15).  
d In the study by Martin, 2014, 21% of service users were reported as being from ophthalmological surgery or clinics, and 22% were not reported. 
Therefore, in order to only use the data regarding inpatients and outpatients, we calculated the percentages of discharged inpatients and outpatients 
using only the total number of callers who were discharged inpatients or outpatients (n = 149).  
e The weighted averages for percentages of discharged inpatients and percentages of discharged outpatients are based upon two of three studies, since 
the sample size was not reported in the study by Teli, 2001. 
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Types of enquiries 1 
Contact reason 2 
Table 4 presents the findings from fifteen studies that reported reasons for contacting a 3 
PMHS. Adverse effects was the category reported as the primary reason for enquiries from six of the 4 
fifteen studies, with a weighted mean of 37% of all enquiries.  5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
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 1 
Table 4. Reason for enquiries reported in studies examining patient medicines helpline services. 
Enquiry category 
Numbers and percentages of studies reporting the specified category as the primary reason 
for enquiries 
Total (N = 15) 
Range of reported 
percentages of enquiries 
(mean; WM) 
Sample size range (Total n) 
    
Adverse effects 6 [9, 20, 27, 34, 35, 37] 21% - 46% (33%; 37%) 56 - 209 (at least 525a) 
Administration or dosage 5 [21, 26, 29, 30, 32] 21% - 52% (37%; 34%) 49 - 538 (1058) 
Interactions 1 [31] 22% 500 
Appropriateness or safety of medicines 1 [13] 50% 637 
Indications, efficacy or mechanisms of action 1 [33] 34% At least 1000 b 
Insufficient information on hospital discharge letter 1 [12] 24% 413 
        
Note. Abbreviations: WM = weighted mean (weighted by sample size). Enquiry categories are listed according to the number of studies within each 
category. There may be overlap between some enquiry categories, since study authors did not use exactly the same categories.  
a Two of the six studies did not report their sample size. 
b This study reported their sample size as 'over 1000'. 
 
 2 
 3 
 4 
 5 
 6 
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Clinical origin of enquiry 1 
Two studies reported the clinical origin of enquiries to their PMHS. For Price et al., [32] the 2 
top three clinical origin of enquiries were Surgery (59%), General Medicine (13%), and Paediatrics 3 
(6%). For Bramley et al., [12] the top three clinical origin of enquiries were Cardiology (20%), General 4 
Medicine (8%), and Ear, Nose and Throat (6%).  5 
Drug classes 6 
Four studies reported the percentage of enquiries by drug class. The largest drug class was 7 
reported to be antimicrobial drugs by two studies (19% and 21% of all enquiries) [25, 31] and 8 
cardiovascular drugs in a third study (27% of all enquiries) [35]. The fourth study, which took place at 9 
a mental health Trust, reported atypical antipsychotics as the main drug class (38% of all enquiries) 10 
[27].  11 
Enquiries regarding medicines-related errors 12 
Table 5 presents six studies that reported the percentage of enquiries that were regarding 13 
medication errors [12, 13, 24, 28, 29, 31]. Combined, the studies suggest that between 8% and 39% 14 
of enquiries concern errors (mean = 31%; weighted mean = 27%). 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
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Table 5. Studies examining the number of enquiries received by patient medicines helpline services that were 
regarding medicines-related errors. 
Author, Year published N 
Total percentage of enquiries 
regarding errors 
Primary error type 
Bramley, 2014 [12] 312 8% Missing medicines (38%) 
Badiani, 2017 [13] 637 39% Transfer of care errors (69%)  
Cuthbert, 2013 [24] 18 33% NR 
Jones, 2014 [28] NR 19% NR 
Law, 2015 [29] 109 20% NR 
Marvin, 2011 [31] 500 34% 
Wrong/insufficient information supplied 
with medicine (49%) 
Note. NR = not reported. There may be overlap between some error type categories, since study authors did not 
use exactly the same categories.  
 
 1 
 2 
 3 
 4 
 5 
 6 
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DISCUSSION 1 
This systematic review synthesised the current evidence regarding the characteristics of 2 
enquirers to PMHS, and the types of enquiries they make. Included studies were all service 3 
evaluations where authors evaluated their own service, and we found the averagerisk of bias in 4 
study articles to be 71%, which we perceive to be high.  5 
Characteristics of enquirers 6 
Our findings suggest that users of PMHS are broadly representative of hospital patients 7 
regarding gender, but not age. The average age of helpline enquirers was 69 years, compared to an 8 
average age of 53 years for hospital patients. This could reflect that older people tend to seek health 9 
information from healthcare professionals directly, compared to younger people who may be more 10 
inclined to seek information online [38, 39].  11 
The age difference may also suggest that PMHS are particularly valued as a source of 12 
support by people who are at heightened risk with their medicines, since there is an association 13 
between age and polypharmacy [40]. Research suggests that polypharmacy increases the risk of 14 
prescribing errors [41], adverse drug reactions [42], drug-drug interactions [40], suboptimal 15 
adherence [43], emergency department visits [44], unplanned hospital admissions [45], and 16 
readmissions [46]. Polypharmacy also increases the likelihood that patients will lack knowledge or 17 
understanding of their medicines [47]. Although no data were found as to the average number of 18 
prescribed medicines consumed at the time of contacting a PMHS, approximately 22% of enquiries 19 
to PMHS in the UK are regarding interactions, suggesting that a number of enquirers are consuming 20 
more than one medicine.  21 
Population projections produced by the Office for National Statistics suggests that there will 22 
be a significant increase in the population of older people in the next two decades [48]. This may 23 
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indicate an increased need for MI services in the future, in order to provide support to this growing 1 
population.  2 
Our findings, in the context of previous evidence, suggest that there are a number of 3 
individuals who may be denied access to some PMHS. We found that 28% of users contacted the 4 
service on behalf of a patient, and that 50% of enquiries to PMHS may be from outpatients 5 
compared to discharged inpatients. A recently conducted survey of PMHS in England reported that 6 
7% of PMHS (eight NHS Trusts) do not provide advice to carers, and that 5% of PMHS do not provide 7 
the service to outpatients [10]. This suggests that a proportion of individuals in need of medicines-8 
related support are not able to access it from these particular PMHS. This is important, since one 9 
study found that approximately 48% of 500 answered enquiries to a PMHS were considered to have 10 
the potential to prevent harm from medicines [31]. This highlights the need to advertise this service, 11 
and make it available, to all patients who may benefit from using it.  12 
Our systematic review found no studies that reported the ethnicity nor educational 13 
level/socioeconomic status of enquirers, nor the average number of medicines consumed. 14 
Additionally, of the eight studies that reported data regarding the characteristics of enquirers, none 15 
of the data were collected within the past five years, suggesting that the relevance and 16 
generalisability of the data are now questionable. 17 
Types of enquiries 18 
Our findings suggest that there is wide variation in the percentages of types of enquiries 19 
received to different PMHS, since six different categories were reported as being the primary reason 20 
for enquiries. This highlights the importance of conducting locally tailored improvement projects 21 
whereby PMHS data for an NHS Trust are used to produce recommendations to improve their own 22 
services.  However, this variation may also be a consequence of sites coding their enquiries using 23 
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unstandardised enquiry category options, and/or possible confusion regarding how to code certain 1 
enquiries (e.g., those that may fit more than one category).  2 
In six of fifteen studies that reported reasons for contacting a PMHS, the largest category of 3 
enquiries to PMHS concerned adverse effects. These findings are congruent with the results from 4 
the UK National Health Service (NHS) annual Adult Inpatient Survey found that, between 2013-2017, 5 
42-44% of patients (n range = 38384-52554) did not recall receiving any information from staff about 6 
side effects [6]. Consequently, by improving medicines-related counselling to patients at hospital 7 
discharge, particularly around side effects, patients may be less likely to need support following 8 
discharge [49]. However, there is always likely to be a need for PMHS to support patients and carers 9 
following patients’ discharge from hospital. Evidence suggests that some patients, particularly the 10 
elderly, may forget or misunderstand aspects of discharge counselling pertaining to their medicines 11 
[3, 50, 51]. Additionally, it could be that even if patients are provided with information about 12 
potential side effects at the time of discharge, they may still require support later on, at the time 13 
when side effects develop.  14 
One proposed benefit of PMHS is that they act as a safety net to identify errors [10].  Our 15 
synthesis suggests that up to 39% of enquiries to PMHS are regarding medicines-related errors, with 16 
a weighted mean of 27%. Medication errors can have significant health and economic consequences, 17 
such as adverse drug reactions, reduced medication efficacy, increased use of healthcare services, 18 
and death [52]. Learning from medicines-related errors in order to implement methods for their 19 
reduction is a current NHS and worldwide healthcare priority [52]. Royal Pharmaceutical Society-20 
endorsed national standards for operating a PMHS are available [53], one of which is having a 21 
mechanism in place to feed back to the Trust medication problems and ‘systems errors’ identified by 22 
patients/carers in order to prevent recurrence. Therefore, a PMHS may provide one avenue for 23 
reducing medicines-related errors, if the information from such enquiries is developed into 24 
recommendations and implemented in order to improve practice. However, it is currently unknown 25 
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what percentage of Trusts currently adhere to this standard, and whether there are specific barriers 1 
preventing this from happening.  2 
Recommendations 3 
Further research is needed to establish patients’ MI needs and preferences, including those 4 
of younger patients. Our findings indicate that enquiries to PMHS are often from elderly patients, 5 
and cross-sectional studies suggest that younger people are more likely to seek health-related 6 
information online compared to older people [39]. However, depending on the source, online 7 
information about medicines may not be as reliable as seeking the advice of a pharmacy professional 8 
with expertise in MI. Therefore, one way to improve the reach of PMHS may be to establish 9 
electronic means to access them, which may be more appealing to younger patients. However, it 10 
would be advantageous to first establish the medicines-related needs of younger patients, and how 11 
best to engage with them to increase their awareness and use of PMHS. 12 
We recommend that PMHS sites conduct service evaluations in order to provide a more 13 
detailed and standardised profile of enquirers (e.g., including ethnicity, educational 14 
level/socioeconomic status, and the average number of medicines consumed by patient enquirers). 15 
This would help to establish how enquirers compare to the local patient population, and to enable 16 
comparisons across sites. Such data could be useful to explore whether certain types of patients are 17 
less likely to use the service. This could result in projects to understand why, and whether more can 18 
be done to provide a service that is equitable and available for all hospital patients who require 19 
support with their medicines.  20 
We encourage providers of PMHS to evaluate the types of enquiries they receive (including 21 
whether they pertain to a medicine error) by using nationally standardised categories and coding 22 
instructions/training materials that are endorsed by the UK Medicines Information network (UKMi). 23 
This will enable the types of enquiries received to be more appropriately compared across sites and 24 
regions within the UK. 25 
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We also encourage sites to use data on types of enquiries to PMHS to produce 1 
recommendations for improving local hospital services. For example, six studies reported that 2 
enquiries were predominantly about adverse effects, and two studies reported that enquiries were 3 
predominantly about antimicrobial drugs. Therefore, potential projects could involve improving 4 
patient leaflets and counselling regarding adverse effects and antimicrobial drugs. Another example 5 
could be for sites to monitor the number of enquiries regarding medication errors to establish 6 
whether using helpline data to improve practice within the hospital results in a reduced number of 7 
calls about errors over time. It would also be useful if sites were more easily able to share learning 8 
from their local projects, for example, having the capability to share brief reports via the UKMi 9 
network. 10 
Strengths and limitations 11 
 This is the first systematic review that has examined the types of enquirers and enquiries of 12 
PMHS. This has resulted in our development of recommendations to improve current practice in the 13 
operation and evaluation of PMHS, and potentially hospital pharmacy services more widely.  14 
 However, the findings of this review may be limited by the small number of studies available 15 
to establish averages for certain enquirer characteristics. For example, our findings regarding the 16 
average age of participants, the average percentage of repeat enquirers, and the weighted average 17 
percentage of inpatients versus outpatients, are all based upon two studies each. Therefore, these 18 
findings should be treated with caution, and also emphasise the need for additional, larger studies to 19 
examine the profile of enquirers to PMHS. 20 
Relatedly, the findings of this review may also be limited due to the potential lack of high-21 
quality studies currently available. Only five of the nineteen studies in this review met our eligibility 22 
criteria for the assessment of quality and risk of bias, since most studies were from conference 23 
abstracts and their content was considered too limited to perform a thorough quality assessment 24 
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upon. We considered the quality of these five studies to be moderate (on average, 48%; range = 1 
29%-65%) and their risk of bias to be high (on average, 71%; range =40%-100%). Therefore, a 2 
limitation of this review is that our quality assessment and risk of bias average scores are only based 3 
upon 26% of the studies included in this review. However, since the remaining 74% of studies 4 
comprised conference abstracts, brief reports, and a letter to an editor, their lack of peer review 5 
may arguably raise concern over their quality, also. 6 
Another limitation of this review concerns our comparison of PMHS findings to HES data, 7 
since the HES data used in this study is not specifically regarding patients that consume medicines. 8 
Also, the HES average age percentage (53%) was calculated from HES admitted patient care data 9 
only, since mean age was not reported in HES outpatient datasets. Therefore, the HES age 10 
percentage used in this study may not be fully representative of the types of patients who may use a 11 
PMHS. Additionally, we compared the findings of this review with HES data over the past five years. 12 
Therefore, the data collection years for the studies included in this review and for the HES data did 13 
not correspond, which will likely affect the comparison. However, the HES data used were relatively 14 
stable over the five years.  15 
 Finally, we did not contact all sites that provide a PMHS in the UK to establish whether any 16 
local unpublished work could be included in this review. Instead, we contacted authors of included 17 
studies within the past ten years to establish the availability of unpublished work from their sites. 18 
Therefore, it is possible that other studies may have been conducted with findings that are relevant 19 
to this review, but which were not included. 20 
Conclusions 21 
 This systematic review synthesised evidence regarding the users of PMHS and the enquiries 22 
they make. The service seems particularly appealing for patients who are vulnerable to experiencing 23 
medicines-related issues following hospital discharge, since PMHS are often used by the elderly, and 24 
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elderly patients are more likely to experience polypharmacy. Additionally, over a quarter of 1 
enquiries to PMHS may concern medicines-related errors, suggesting that addressing such errors is 2 
an important function of this service. However, our study findings may be limited by a high risk of 3 
bias within included studies. Further research could provide a more detailed profile of helpline users 4 
(e.g., ethnicity, average number of medicines consumed). We recommend standardising the way 5 
that PMHS data are categorised and reported so that data are more easily comparable and collated 6 
across sites for a more generalisable picture of PMHS use. We encourage PMHS providers to use 7 
routinely collected data to conduct local quality improvement projects (e.g., to reduce medicines-8 
related errors, and improve patient MI leaflets/counselling), and to share project findings with other 9 
PMHS providers.  10 
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Supplementary Information 1. Search strategy for EMBASE. 2 
Supplementary Information 2. Grey literature sources searched. 3 
Supplementary Information 3. Data extraction form. 4 
FIGURE LEGENDS 5 
Figure 1. Flow diagram of the study selection process 6 
a Forward and backward citation searches, grey literature databases, Google and Google Scholar, 7 
targeted websites/sources, and consultation with experts. 8 
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Figure 1. Flow diagram of the study selection process 
a Forward and backward citation searches, grey literature databases (OpenGrey and ProQuest 
database for dissertations and theses), Google and Google Scholar, targeted websites/sources, and 
consultation with experts. 
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Supplementary Information 1. Search strategy for EMBASE 
 
#1 'hotline'/exp AND ([embase]/lim OR [embase classic]/lim) 
#2 hotline*:ti,ab OR 'hot$line*':ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#3 helpline*:ti,ab OR 'help$line*':ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#4 'telephone'/exp AND ([embase]/lim OR [embase classic]/lim) 
#5 telephone*:ti,ab OR phone*:ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#6 'e-mail'/exp AND ([embase]/lim OR [embase classic]/lim) 
#7 email*:ti,ab OR 'e-mail*':ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#8 'internet'/exp AND ([embase]/lim OR [embase classic]/lim) 
#9 'internet*':ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#10 online:ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#11 webform*:ti,ab OR 'web$form*':ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#12 webpage*:ti,ab OR 'web$page*':ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#13 website*:ti,ab OR 'web$site*':ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#14 'web$based':ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#15 'mobile application'/exp AND ([embase]/lim OR [embase classic]/lim) 
#16 (((mobile NEXT/2 app):ti,ab) OR ((mobile NEXT/2 apps):ti,ab) OR ((mobile NEXT/2 
application*):ti,ab)) AND ([embase]/lim OR [embase classic]/lim) 
#17 'mobile device*':ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#18 ('social network*' OR twitter OR tweet* OR facebook OR 'instant messag*' OR 'SMS'):ti,ab AND 
([embase]/lim OR [embase classic]/lim) 
#19 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 
OR #15 OR #16 OR #17 OR #18 
#20 'pharmacy'/exp AND ([embase]/lim OR [embase classic]/lim) 
#21 'clinical pharmacy'/exp AND ([embase]/lim OR [embase classic]/lim) 
#22 'hospital pharmacy'/exp AND ([embase]/lim OR [embase classic]/lim) 
#23 'pharmacy school'/exp AND ([embase]/lim OR [embase classic]/lim) 
#24 (pharmacy:ti,ab OR pharmacies:ti,ab) AND ([embase]/lim OR [embase classic]/lim) 
#25 'pharmacist'/exp AND ([embase]/lim OR [embase classic]/lim) 
#26 'pharmacy technician'/exp AND ([embase]/lim OR [embase classic]/lim) 
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#27 pharmacist*:ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#28 #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 
#29 ((drug* OR medicine* OR medication*) NEAR/5 (information OR advice OR support OR enquir* 
OR inquir*)):ti,ab AND ([embase]/lim OR [embase classic]/lim) 
#30 #19 AND #28 AND #29 
#31 (telepharmac*:ti,ab OR 'tele$pharmac*':ti,ab) AND ([embase]/lim OR [embase classic]/lim) 
#32 ('epharmac*':ti,ab OR 'e$pharmac*':ti,ab) AND ([embase]/lim OR [embase classic]/lim) 
#33 ((drug* OR medicine* OR medication*) NEAR/5 (hotline* OR hot$line*)):ti,ab AND 
([embase]/lim OR [embase classic]/lim) 
#34 ((drug* OR medicine* OR medication*) NEAR/5 (helpline* OR help$line)):ti,ab AND 
([embase]/lim OR [embase classic]/lim) 
#35 ((drug* OR medicine* OR medication*) NEAR/5 'call cent*'):ti,ab AND ([embase]/lim OR 
[embase classic]/lim) 
#36 ((drug* OR medicine* OR medication*) NEAR/5 'information cent*'):ti,ab AND ([embase]/lim OR 
[embase classic]/lim) 
#37 ((drug* OR medicine* OR medication*) NEAR/5 'information service*'):ti,ab AND ([embase]/lim 
OR [embase classic]/lim) 
#38 ((drug* OR medicine* OR medication*) NEAR/5 'information line*'):ti,ab AND ([embase]/lim OR 
[embase classic]/lim) 
#39 #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 
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Supplementary Information 2. Grey literature search strategy 
Godin et al. recommend applying a systematic approach when searching for grey literature 
[1].  Following their recommendations, four grey literature sources were searched: 
1) Grey literature databases. OpenGrey and ProQuest database for dissertations and theses were 
searched using the following search terms: ‘medicines information’, ‘medicines helpline’, ‘drug 
information’, and ‘drug helpline’.  
2) Google and Google Scholar. The Google search involved evaluating the relevance of all available 
hits when searching for the exact terms ‘patient medicines helpline’, ‘medicines information centre’, 
‘drug information helpline’, ‘drug information center’, and ‘drug information service’. The Google 
Scholar search involved evaluating the relevance of all available hits when searching for the exact 
terms ‘patient medicines helpline’, ‘medicines information centre’ , ‘drug information helpline’, 
‘drug information center’, and ‘drug information service’, and then repeating the searches when 
limiting the terms to appearing in the title only. Limiting the search to ‘title only’ was recommended 
by Haddaway et al. [2], who conducted an evaluation using Google Scholar to search for grey 
literature in seven published systematic reviews. 
3) Targeted websites/sources. Proceedings from the following UK conferences were searched: UK 
Medicines Information Practice Development Seminar (1995-2017), Royal Pharmaceutical Society 
Conference (formerly called British Pharmaceutical Conference; 1992-2017), Health Services 
Research and Pharmacy Practice Conference (1995-2018), and International Social Pharmacy 
Workshop (2004-2018). 
4) Consultation with experts. The main author of all included studies that were published within the 
last ten years were contacted, requesting details of any similar research already completed or being 
carried out, providing that a report of the findings was drafted. 
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Data extraction form 
 
Source of study: 
 
 
Title:  
 
 
Author: 
 
 
Year published: 
 
 
Year of data collection: 
 
 
Study design/s: 
 
 
Type of service (i.e., is it a PMHS?): 
 
 
Number of participants/enquiries: 
 
 
Outcomes: 
 
 
Details of analysis: 
 
 
Additional comments: 
 
 
